sign free newsletters sign free newsletters unethical risky ignore racial ethnic minorities nearly 40 percent americans belong racial ethnic minority patients participate clinical trials new drugs skew heavily white cases 80 90 percent nonwhite patients ultimately drugs come clinical studies leads real problem symptoms conditions heart disease cancer diabetes contributing factors vary lines ethnicity sexes diverse groups not studies not sure treatment work populations effects emerge group not new concern 1993 congress passed national institutes health revitalization act required agency include women people color research studies step right direction sure percentage women clinical trials grown significantly participation minorities not increased